GSK Stock Price, Chart, Stats & News

GSK plc
Save
GSK chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 72.54% |
Operating margin | 24.28% |
Pretax margin | 22.66% |
Net margin | 17.50% |
Effective tax rate | 15.02% |
ROA | 9.37% |
ROE | 29.84% |
D/E | 1.08x |
Interest coverage ratio | 11.35x |
GSK valuation
P/E | 11.91x |
P/S | 2.50x |
P/B | 4.99x |
P/CF | 9.82x |
P/FCF | 13.12x |
P/OCF | 9.82x |
PEG | 4.29x |
EV multiple | 5.81x |
About
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally.
Similar securities
Based on sector and market capitalization
Report issue











